Zoe, a London-based nutrition company, has recently expanded its operations in the United States following a successful $15 million Series B extension funding round.
Zoe provides customers with at-home testing kits to collect blood or feces samples for analyzing blood fat, blood sugar, and gut microbiome health. Based on the results, the company assigns a score to every food item, allowing individuals to make more informed dietary choices.
In addition to personalized food scoring, Zoe educates users on food substitutions, additions, and combinations tailored to their individual needs. The company also monitors users’ gut microbiome health throughout their dietary journey.
The recent investment from U.S.-based Coefficient Capital brings Zoe’s total funding to $118 million, including a previous raise of £25 million ($30 million) in 2022.
The funding follows a randomized controlled trial published in Nature Medicine in May 2024, showcasing the impact of personalized nutrition on cardiometabolic health. This trial adds to Zoe’s portfolio of over 60 peer-reviewed scientific papers, aimed at validating the effectiveness of microbiome mapping.
CEO Jonathan Wolf emphasized the rigor of the trial and the commitment to data transparency, ensuring unbiased reporting of outcomes.
The trial results demonstrated the effectiveness of Zoe’s approach in improving biological markers and overall well-being within a few months of implementation. Users reported enhancements in mood, sleep quality, and energy levels, exceeding initial expectations.
While weight loss remains a prevalent goal, Zoe’s focus is on promoting better nutrition rather than solely targeting weight reduction. The company’s evidence-based approach challenges traditional dietary advice and emphasizes the personalized nature of dietary guidance.
Wolf highlighted the rapid growth in Zoe’s customer base, with over 100,000 paid subscribers opting for the company’s 12-month subscription plan at $29 per month in the U.S.
To further expand its reach in the U.S., Zoe is leveraging the recent funding to address regulatory hurdles and enhance its marketing efforts, anticipating a significant impact on public health and nutrition awareness.
